Mode
Text Size
Log in / Sign up
N/A N=145 Randomized Treatment

Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla

Jaw, Edentulous, Partially

Enrolled (actual)
145
Serious AEs
1.4%
Results posted
Aug 2012
Primary outcome: Primary: Mean Change in Bone Level (Distance B) After 6 Months Compared to Baseline (=Surgery) — -0.32; -0.29 millimeters

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Straumann Bone Level Implant (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Institut Straumann AG
Primary completion
Jun 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Change in Bone Level (Distance B) After 6 Months Compared to Baseline (=Surgery)
-0.32; -0.29
SECONDARY
Implant Survival Rate
100; 98.3
SECONDARY
Implant Survival Rate
100; 98.3

Summary

The purpose of this study is To demonstrate that there is no difference in change in bone level around P.004 implants between 1st stage surgery and 6 months post surgery when transmucosal implant placement is compared to submerged implant placement

Eligibility Criteria

Inclusion Criteria

  • Males and females >18 years of age.
  • Implant placement planned in the anterior maxilla or mandible (FDI tooth numbers 21 - 25, 11 - 15, 31-35, 41-45).
  • Tooth site must have a natural tooth both mesially and distally in the adjacent tooth positions
  • Opposing dentition of natural teeth, or tooth or implant-supported fixed restorations.
  • Adequate bone quality and quantity at the implant site to permit the insertion of a Straumann P.004 SLActive implant of 8, 10, 12, or 14 mm length.
  • Presence of a sufficient band of keratinized mucosa (min. 2 mm) to allow surgical manipulation and suturing according to the protocol
  • Signed informed consent document before being treated in the study

Exclusion Criteria

  • Systemic disease that would interfere with dental implant therapy (e.g. uncontrolled diabetes)
  • Any contraindications for oral surgical procedures
  • Current untreated periodontitis or gingivitis
  • Probing pocket depth of more than 4 mm at one of the adjacent teeth
  • Mucosal diseases (e.g. erosive lichen planus)
  • History of local irradiation therapy
  • Bone augmentation procedures if the procedure require healing time of more than 12 weeks after implant placement
  • Implants in adjacent position to planned implant
  • Severe bruxing or clenching habits
  • Heavy smokers: Patients who smoke more than 20 cigarettes per day
  • Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation.
  • Patients with inadequate oral hygiene or unmotivated for adequate home care

Secondary Exclusion Criteria at Implant Surgery:

  • Lack of primary stability of the implant
  • Inappropriate implant position to insert implants according to the prosthetic requirements.
  • Patients with augmentation procedures requiring more than 12 weeks healing time.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00906425). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search